Table 2.
Biochemical and hematological measurements of the study patients
| Variable | NSTEMI SYNTAX score ≥32 (n=35) | NSTEMI SYNTAX score <32 (n=45) | NCA (n=29) | P* | P§ | Pβ | Pα |
|---|---|---|---|---|---|---|---|
| WBC count, x109/L | 9.20±2.15 | 8.81±2.12 | 7.52±1.59 | 0.003 | 0.668 | 0.003 | 0.024 |
| Platelet count, x109/L | 238.91±70.66 | 248.83±74.45 | 249.46±66.39 | 0.787 | |||
| Hemoglobin, g/dL | 13.79±1.63 | 13.82±1.76 | 13.37±1.28 | 0.494 | |||
| Serum glucose, mg/dL | 151.92±72.33 | 131.08±47.76 | 133.75±45.02 | 0.234 | |||
| Creatinine, mg/dL | 0.99±0.26 | 1.12±0.78 | 0.91±0.113 | 0.234 | |||
| Peak CK-MB, U/L | 45.70 (15–229) | 37.46 (0–131) | – | 0.488 | |||
| Peak troponin-T, ng/mL | 4.51 (0–34.7) | 5.27 (0.09–31.00) | – | 0.884 | |||
| Total cholesterol, mg/dL | 199.71±49.03 | 188.44±55.27 | 176.20±45.28 | 0.237 | |||
| HDL-cholesterol, mg/dL | 47.65±12.56 | 46.18±10.11 | 58.54±16.91 | 0.001 | 0.876 | 0.006 | 0.001 |
| LDL-cholesterol, mg/dL | 118.96±42.78 | 112.18±45.09 | 98.75±37.77 | 0.215 | |||
| Triglyceride, mg/dL | 174.84±113.24 | 150.76±91.30 | 147.13±79.68 | 0.479 | |||
| Hs-CRP, mg/L | 4.02±0.81 | 3.32±1.23 | 1.58±0.59 | <0.001 | 0.005 | <0.001 | <0.001 |
| Glomerular filtration rate, mL/min/1.73 m2 | 75.31±17.10 | 76.64±20.21 | 80.30±9.11 | 0.706 | |||
| Adropin, pg/mL | 2357.30±821.58 | 3077.00±912.86 | 3688.00±956.65 | <0.001 | 0.003 | <0.001 | 0.016 |
CK-MB - creatine kinase-myocardial band; HDL - high density lypoprotein; hs-CRP - high sensitivity C-reactive protein; LDL - low density lypoprotein; NCA - normal coronary artery; NSTEMI - Non ST-segment elevation myocardial infarction; WBC - white blood cell.
P*
- P value between all groups;
P§
- P value between SYNTAX score <32 and SYNTAX score ≥32;
P - P value between SYNTAX score 32 and controls; P - P value between SYNTAX score <32 and controls